Late-onset vitamin K deficiency bleeding in an extremely preterm infant fed an exclusively human milk-based diet.
hemorrhage
human
milk
nutrients
nutrition
premature birth
vitamin K
Journal
Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508
Informations de publication
Date de publication:
20 Nov 2023
20 Nov 2023
Historique:
received:
10
10
2023
revised:
27
10
2023
accepted:
31
10
2023
pubmed:
20
11
2023
medline:
20
11
2023
entrez:
19
11
2023
Statut:
aheadofprint
Résumé
All newborns need extra phylloquinone (vitamin K
Identifiants
pubmed: 37981048
pii: S1538-7836(23)00831-0
doi: 10.1016/j.jtha.2023.10.029
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interests V.V. was involved in recruitment to a clinical trial that randomized preterm-born infants to an exclusively human milk diet [1]. P.C. declares unrestricted research funding paid to his employing institution (Norfolk and Norwich University Hospitals NHS Foundation Trust) by Danone Early Life Nutrition and conference travel and accommodation reimbursements received from Nutricia and Nestle in 2018 to 2019 and, in 2018 to 2020, was local principal investigator recruiting to a commercial trial of a novel bovine-derived breast milk fortifier sponsored by Danone Nutricia Research. M.J.S. has acted as a medicolegal expert witness in cases of vitamin K deficiency bleeding. The authors have no other potential conflicts of interest relevant to this article to disclose.